Gene: CHST3
Official Full Name: carbohydrate sulfotransferase 3provided by HGNC
Gene Summary: This gene encodes an enzyme which catalyzes the sulfation of chondroitin, a proteoglycan found in the extracellular matrix and most cells which is involved in cell migration and differentiation. Mutations in this gene are associated with spondylepiphyseal dysplasia and humerospinal dysostosis. [provided by RefSeq, Mar 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33218 | CHST3 Knockout cell line (HeLa) | Human | CHST3 | 1:3~1:6 | Negative | Online Inquiry |
KO33219 | CHST3 Knockout cell line (HCT 116) | Human | CHST3 | 1:2~1:4 | Negative | Online Inquiry |
KO33220 | CHST3 Knockout cell line (HEK293) | Human | CHST3 | 1:3~1:6 | Negative | Online Inquiry |
KO33221 | CHST3 Knockout cell line (A549) | Human | CHST3 | 1:3~1:4 | Negative | Online Inquiry |
CHST3 Gene Knockout Cell Lines are genetically modified cell lines in which the CHST3 gene has been precisely inactivated or "knocked out." This product allows researchers to study the specific functions and downstream effects of the CHST3 gene, which encodes an enzyme involved in glycosaminoglycan synthesis. By eliminating this gene’s activity, the CHST3 knockout cell lines facilitate investigations into the molecular and cellular mechanisms that underpin diverse biological processes and disease states, particularly those related to extracellular matrix composition and cell signaling.
The key function of CHST3 is in the biosynthesis of specific carbohydrate structures, notably those associated with proteoglycans. Through targeted mechanisms such as CRISPR-Cas9 gene editing, our CHST3 knockout cell lines enable scientists to explore the role of CHST3 in cellular processes, including cell adhesion, migration, and proliferation, providing a crucial understanding of its implication in conditions like cancer and developmental disorders.
These cell lines hold significant scientific value, with applications ranging from basic research to therapeutic developments. They are especially useful in drug discovery endeavors that aim to investigate potential interventions for diseases associated with abnormal glycosaminoglycan metabolism. Compared to alternative models, such as wild-type cell lines or pharmacological inhibitors, the CHST3 knockout cell lines offer a direct approach to understanding the gene's function devoid of compensatory mechanisms, thereby providing clearer insights into gene-related pathways.
For researchers and clinicians, employing CHST3 gene knockout cell lines can accelerate breakthroughs in understanding disease mechanisms and developing targeted therapies, ensuring their relevance in contemporary biomedical research. Our company specializes in the development and refinement of genetically modified models, ensuring high-quality products that meet rigorous laboratory standards. We leverage cutting-edge technology and extensive expertise in molecular biology to provide innovative tools that empower our customers in their scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.